Menopausal effects on presentation, treatment, and survival of women with non–small cell lung cancer Kimberly A Moore, MD, Carlos M Mery, MD, MPH, Michael.

Slides:

Advertisements

Similar presentations

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Advertisements

Elizabeth A. David, MD, David T

Gender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002 Antonio L Visbal, MD, Brent.

Thomas J. Birdas, MD, Richard P. M

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

Relationship between margin distance and local recurrence among patients undergoing wedge resection for small (≤2 cm) non–small cell lung cancer Kamran.

Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A

Malignant minor pleural effusion detected on thoracotomy for patients with non–small cell lung cancer: is tumor resection beneficial for prognosis? Noriyoshi.

Quality of life after tailored combined surgery for stage I non–small-cell lung cancer and severe emphysema Eugenio Pompeo, MD, Enrico De Dominicis,

Joshua E. Rosen, BASc, Hari B

Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.

Lung cancer staging and treatment in multidisciplinary trials: cancer and leukemia group B cooperative group approach1 Mark J Krasna, MD, Carolyn E Reed,

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,

Lung Cancer Staging: A Case for a New T Definition

Philip A. Linden, MD, Richard J. Gilbert, MD, Beow Y

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Esophageal Resection for Cancer of the Esophagus: Long-Term Function and Quality of Life Allison J McLarty, MD, Claude Deschamps, MD, Victor F Trastek,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Andrea S. Wolf, MD, MPH, Scott J

Sex-associated differences in survival of patients undergoing resection for lung cancer Mark K Ferguson, MD, Jun Wang, MD, Philip C Hoffman, MD, Daniel.

Patterns of survival and recurrence after surgical treatment of early stage non–small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial Stacey.

Lung Cancer Surgery in Patients With Liver Cirrhosis

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Thomas J. Birdas, MD, Richard P. M

Andrea S. Wolf, MD, William G. Richards, PhD, Michael T

Prognostic factors in clinical stage I non–small cell lung cancer

Visceral pleural involvement in nonsmall cell lung cancer: prognostic significance Toshihiro Osaki, MD, PhD, Akira Nagashima, MD, PhD, Takashi Yoshimatsu,

Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database Laura C. Caprario, MD, MS,

Surgical Dilemmas: Diagnosis and Treatment of Atrial Plasmacytoma

Elizabeth A. David, MD, MAS, Stina W. Andersen, PhD, Laurel A

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Management of stage IIIA (N2) non–small cell lung cancer: A transatlantic perspective Gaetano Rocco, MD, Katie Nason, MD, MPH, Alex Brunelli, MD, Gonzalo.

Short-course induction chemoradiotherapy with paclitaxel for stage III non-small-cell lung cancer Thomas W Rice, MD, David J Adelstein, MD, Jay P Ciezki,

Patient Preferences in Treatment Choices for Early-Stage Lung Cancer

Pulmonary Resection for Lung Cancer in Octogenarians

Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung Marc Riquet, MD, Dominique Manac’h, MD, Françoise Le.

Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non–Small Cell Lung Cancer Morihito Okada, MD, PhD, Toshihiko Sakamoto, MD, PhD, Tsuyoshi.

Characteristics of Malignant Pleural Mesothelioma in Women

Radiofrequency Ablation for Stage I Non-Small Cell Lung Cancer: Management of Locoregional Recurrence Michael Lanuti, MD, Amita Sharma, MD, Henning Willers,

Douglas E. Paull, MD, Glenda M. Updyke, PA-C, Michael A

Sequential thoracic metastasectomy prolongs survival by re-establishing local control within the chest Michael T. Jaklitsch, MDa, Carlos M. Mery, MDa,

Modified T-Tube Repair of Delayed Esophageal Perforation Results in a Low Mortality Rate Similar to That Seen With Acute Perforations Philip A. Linden,

Carlos E. Bravo Iñiguez, MD, Katherine W

James D Luketich, Michael E Burt The Annals of Thoracic Surgery

Beware the malignant jellyfish

Philip A. Linden, MD, Jon O. Wee, MD, Michael T

Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma Scott.

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Edwin van Velzen, MD, Aart Brutel de la Rivière, MD, PhD, Hans J

Linda W. Martin, MD, MPH, FCCP, FACS, Gail E

Neal S Goldstein, MD The Annals of Thoracic Surgery

Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer Steven M Keller, MD, Sudeshna Adak,

Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,

Nonanatomic prognostic factors in resected nonsmall cell lung carcinoma: the importance of perineural invasion as a new prognostic marker Adnan Sayar,

Walter J. Scott, MD, James Shepherd, MS, Sanjiv Sam Gambhir, MD, PhD

Aritoshi Hattori, MD, Kenji Suzuki, MD

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Surveillance Epidemiology and End Results Evaluation of the Role of Surgery for Stage I Small Cell Lung Cancer James B. Yu, MD, Roy H. Decker, MD, PhD,

Mark I. Block, MD The Annals of Thoracic Surgery

Survival and Prognosis After Pneumonectomy for Lung Cancer in the Elderly Yutaka Mizushima, Hirofumi Noto, Shigeki Sugiyama, Yoshinori Kusajima, Ryouhei.

Bryan M. Burt, MD, Santiago Ocejo, MD, Carlos M

Presentation transcript:

Menopausal effects on presentation, treatment, and survival of women with non–small cell lung cancer Kimberly A Moore, MD, Carlos M Mery, MD, MPH, Michael T Jaklitsch, MD, Anastasia P. Estocin, MPH, Raphael Bueno, MD, Scott J Swanson, MD, David J Sugarbaker, MD, Jeanne M Lukanich, MD The Annals of Thoracic Surgery Volume 76, Issue 6, Pages 1789-1795 (December 2003) DOI: 10.1016/S0003-4975(03)01024-5

Fig 1 Kaplan–Meier curves for lung cancer-related survival (months) in premenopausal (—) and postmenopausal ( · · · · · ) women with non–small cell lung carcinoma in all stages (A) and stages I and II (B). The Annals of Thoracic Surgery 2003 76, 1789-1795DOI: (10.1016/S0003-4975(03)01024-5)

Fig 2 (A) Kaplan–Meier curves for lung cancer-related survival (months) in (A) premenopausal women ( · · · · · ) and younger men (—) and (B) postmenopausal women ( · · · · · ) and older men (—) with all stages of non–small cell lung carcinoma. Results indicate a survival advantage for women when compared with their male counterparts. The Annals of Thoracic Surgery 2003 76, 1789-1795DOI: (10.1016/S0003-4975(03)01024-5)